Nearsightedness
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Nearsightedness

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Nearsightedness Local Doctors?
Elite in Nearsightedness
Elite in Nearsightedness

Scheie Eye Institute Perelman

3400 Civic Center Boulevard, West Pavilion, 3rd Floor, 
Philadelphia, PA 
Languages Spoken:
English
Accepting New Patients

Dwight Stambolian is an Ophthalmologist practicing medicine in Philadelphia, Pennsylvania. Dr. Stambolian is rated as an Elite provider by MediFind in the treatment of Nearsightedness. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Nearsightedness, and Geographic Atrophy. Dr. Stambolian is board certified in Ophthalmology, 1988. Dr. Stambolian is currently accepting new patients.

Elite in Nearsightedness
Elite in Nearsightedness
168 Litang Road, 
Changping, CN 

Jost Jonas practices practicing medicine in Changping, China. Jonas is rated as an Elite expert by MediFind in the treatment of Nearsightedness. They are also highly rated in 31 other conditions, according to our data. Their clinical expertise encompasses Nearsightedness, Ocular Hypertension (OHT), Glaucoma, Cataract Removal, and Vitrectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Nearsightedness
Ophthalmology
Distinguished in Nearsightedness
Ophthalmology

Vitreous Retina Macula Consultants Of New York

950 3rd Ave, 3rd floor, 
New York, NY 
Experience:
21+ years
Languages Spoken:
English

Dr. Yannuzzi has made numerous innovative and lasting contributions in imaging, drug development, and therapeutic modalities. He was the first to use oral non-steroid anti-inflammatory medication for the treatment of cystoid macular edema and developed an eye drop to treat this condition. He has described new diseases as well as new associations and manifestations of established entities and photosensitization.He has published over 400 scientific papers and 13 books, which have earned him respect and admiration in the ophthalmic-retinal community and retina specialists internationally. He is well recognized as a devoted and excellent educator, a superb clinical diagnostician, and a prolific organizer of retinal meetings worldwide. Dr. Yannuzzi is rated as a Distinguished provider by MediFind in the treatment of Nearsightedness. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Adult-Onset Vitelliform Macular Dystrophy (AVMD), and Vitrectomy.

What are the latest Nearsightedness Clinical Trials?
Safety and Efficacy of T10430 Eye Drops in Controlling Paediatric Myopia Progression

Summary: Axial myopia is a type of nearsightedness that happens when the eye is too long from front to back. This causes distant vision to be blurry. Axial myopia tends to start during childhood and worsens over time (as the eyes continue to grow longer). This can lead to serious eye-related conditions later in life. The aim of T10430 treatment is to stop or slow this progression during childhood and there...

Match to trials
Find the right clinical trials for you in under a minute
Get started
INTACS® Prescription Inserts Used to Treat Patients With Keratoconus as a Humanitarian Use Device

Summary: The US food and Drug Administration (FDA) originally approved INTACS prescription inserts in April 1999 for the correction of low levels of nearsightedness (-1.00 to -3.00 diopters). Additional clinical data have shown that INTACS are safe for the treatment of keratoconus, in July 2004, FDA approved INTACS inserts for the treatment of keratoconus as a Humanitarian Use Device (FDA approval letter a...